Veronica Ashton

14PUBLICATIONS
11CO-AUTHORS
Behavioural epidemiologyRespiratory diseasesAutonomic nervous systemComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 15, 2025
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Venous Thromboembolism Patients with Comorbid Obstructive Sleep Apnea: A Retrospective Cohort Study.

Craig I Coleman, Nitesh Sood, Cindy Chen

|Mar 25, 2025
Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban.

Veronica Ashton, Guillaume Germain, Julien Boudreau

|Jan 10, 2025
Health Care Resource Use and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Polypharmacy Patients With Obesity.

Mark Alberts, Jinghua He, Akshay Kharat

|Nov 25, 2024
Clinical and economic outcomes with rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and obstructive sleep apnea: retrospective analysis of US healthcare claims.

Andrea Natale, Sanghamitra Mohanty, Cindy Chen

|Sep 24, 2024
Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based Analysis.

Michael Ingham, Hela Romdhani, Aarti Patel

|Mar 25, 2024
Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.

George Bakris, Pei Paul Lin, Chang Xu

Pageof 3

Frequent Collaborators

6 joint publications

Kenneth Todd Moore

5 joint publications

François Laliberté

5 joint publications

Dominique Lejeune

2 joint publications

Craig I Coleman